Tag Archives | N Mbaziira

Quality and Safety of HIV/AIDS Medicines in Namibia October 2015-September 2016

In the last five years, SIAPS has provided technical assistance to the Namibia Medicines Regulatory Council (NMRC) to strengthen its capacity for registration and quality testing by training technical staff in medicines dossier evaluation, developing guidelines for conducting the routine PMS of quality of medicines, and collecting medicine samples at selected ART and TB treatment sites for laboratory testing. SIAPS mentored and provided guidance and technical support to NMRC staff and other personnel in conducting efficient dossier reviews for the registration of ARVs, anti-TB, and other essential medicines. Consequently, intensive dossier review sessions were organized and fully funded by NMRC after effective and successful transition of the activity to NMRC for sustainability. SIAPS provided technical assistance to the NMRC to develop guidelines and collect medicine samples from seven priority regions (Kavango East and West, Khomas, Ohangwena, Omusati, Oshana, Oshikoto, and Zambezi) and one urban hotspot (Grootfontein [Otjozondjupa]).

Read full story · Comments are closed

Registration and Quality Assurance of ARVs and other Essential Medicines in Namibia

SIAPS provided technical assistance to facilitate the expedited assessment and registration of new and existing ARV formulations to support the implementation of the revised Namibian ART guidelines (dated January 2014). The technical assistance focused on improving the efficiency of the regulatory system so that the recommended new first-line fixed-dose combination ARVs that contain tenofovir and emtricitabine for adults; optimized ARV formulations for pediatric use; and other medicines for HIV and AIDS; TB; maternal, newborn, and child health (MNCH); and other public health diseases are assessed and considered for registration and made available for public procurement in a timely manner to benefit patients undergoing ART.

Read full story · Comments are closed

Post-Qualification Monitoring and Evaluation of Pharmacist Assistants Trained at the National Health Training Centre in Namibia

Namibia has a decentralized public health system with 14 administrative regions. It is challenged by a dual burden of HIV and AIDS and tuberculosis (TB) as well as by the persistent shortage of pharmaceutical personnel. Well-trained pharmacist assistants (PA) are central to ensuring that the correct medicines are available in sufficient quantities as well as for counseling patients on the proper use of medicines and monitoring patients’ adherence to antiretroviral therapy (ART) and other treatments. The National Health Training Centre (NHTC) has conducted this first formal workplace assessment of PAs who have graduated from the institution since 2007 in response to support from the US Agency for International Development (USAID) for a series of systematic interventions to strengthen the capacity and quality of PA training. Broadly, the USAID-funded SIAPS program supported the NHTC to conduct a tracer study to inform strategies for improving the PA training program and its reaccreditation by the Namibia Qualifications Authority (NQA). Specifically, the study assessed: the proportion of NHTC PA graduates who are working in a PA role; the PAs’ satisfaction with the training they received at the NHTC; employers’/supervisors’ satisfaction with the PAs’ services; and strengths and weaknesses of the PA training program. Stakeholders’ recommendations for improving the PA training program were also obtained.

Read full story · Comments are closed

Strengthening the Capacity of the Namibia Medicines Regulatory Council in the Regulation of Antiretroviral Medicines and Other Essential Pharmaceuticals

This consultancy and assessment is the follow up to the original 2009 SPS report, which described the structure and function of the NMRC, identified challenges in its operations, and provided recommendations for improvements in the NMRC’s processes. In this consultancy, several substantive recommendations are made to enhance the effectiveness and efficiency of the NMRC, particularly in the registration of ARV/AM/ATB medications and to accelerate the processing of medicines on the Namibian EML.

Read full story · Comments are closed